Anilinoquinazaolines as protein tyrosine kinase inhibitors
US7084147B2 · kind B2 · utility
6Cited by
11References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 2005 |
| Grant date | Aug 1, 2006 |
| Priority date | — |
| Expiry date | Mar 16, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Heteroaromatic compounds are described, methods for their preparation, pharmaceutical compositions containing them, methods of use, and their use in medicines. In particular, the invention relates to quinazoline and pyridopyrimidine derivatives which exhibit protein tyrosine kinase inhibition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.